India's First Indigenously Developed Vaccine Against Cervical Cancer
Presentation by Reshma S Nair
Pune-based pharmaceutical firm Serum Institute of India (SII) and the Department of Biotechnology (DBT) will launch India’s first indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer on Thursday, September 1, 2022, media reports said. The qHPV vaccine is called CERVAVAC.
Last month, the Drugs Controller General of India (DCGI) granted market authorisation to SII to manufacture an indigenously developed vaccine for the prevention of cervical cancer.
Cervical cancer
Hpv
Human papillomavirus
HPV vaccine
Vaccine
India
India's first vaccine
Serum institute of India
Strains
#cancervaccine
#vaccine
#medicalupdation
![](https://i.ytimg.com/vi/I2POdWLm-DM/mqdefault.jpg)